Olsson CA - Search Results

1

Enhanced expression of the c-myc protooncogene in high-grade human prostate cancers.

Buttyan R, Sawczuk IS, Benson MC, Siegal JD, Olsson CA. Buttyan R, et al. Among authors: olsson ca. Prostate. 1987;11(4):327-37. doi: 10.1002/pros.2990110405. Prostate. 1987. PMID: 2446300

2

Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay.

Katz AE, Olsson CA, Raffo AJ, Cama C, Perlman H, Seaman E, O'Toole KM, McMahon D, Benson MC, Buttyan R. Katz AE, et al. Among authors: olsson ca. Urology. 1994 Jun;43(6):765-75. doi: 10.1016/0090-4295(94)90132-5. Urology. 1994. PMID: 7515202

3

Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.

Colombel M, Symmans F, Gil S, O'Toole KM, Chopin D, Benson M, Olsson CA, Korsmeyer S, Buttyan R. Colombel M, et al. Among authors: olsson ca. Am J Pathol. 1993 Aug;143(2):390-400. Am J Pathol. 1993. PMID: 7688182 Free PMC article.

4

Development of a hammerhead ribozyme against bcl-2. I. Preliminary evaluation of a potential gene therapeutic agent for hormone-refractory human prostate cancer.

Dorai T, Olsson CA, Katz AE, Buttyan R. Dorai T, et al. Among authors: olsson ca. Prostate. 1997 Sep 1;32(4):246-58. doi: 10.1002/(sici)1097-0045(19970901)32:4<246::aid-pros4>3.0.co;2-h. Prostate. 1997. PMID: 9288183

5

Immediate induction of c-fos and c-myc transcripts following unilateral nephrectomy.

Sawczuk IS, Olsson CA, Hoke G, Buttyan R. Sawczuk IS, et al. Among authors: olsson ca. Nephron. 1990;55(2):193-5. doi: 10.1159/000185951. Nephron. 1990. PMID: 2113996

6

Flow cytometric analysis of localized adenocarcinoma of the prostate: the use of archival DNA analysis in conjunction with pathological grading to predict clinical outcome following radical retropubic prostatectomy.

Ring KS, Karp FS, Olsson CA, O'Toole K, Bixon R, Benson MC. Ring KS, et al. Among authors: olsson ca. Prostate. 1990;17(2):155-64. doi: 10.1002/pros.2990170209. Prostate. 1990. PMID: 2399191

7

Calcium channel antagonists delay regression of androgen-dependent tissues and suppress gene activity associated with cell death.

Connor J, Sawczuk IS, Benson MC, Tomashefsky P, O'Toole KM, Olsson CA, Buttyan R. Connor J, et al. Among authors: olsson ca. Prostate. 1988;13(2):119-30. doi: 10.1002/pros.2990130204. Prostate. 1988. PMID: 3140224

8

Does year of radical prostatectomy independently predict outcome in prostate cancer?

Mitchell RE, Shah JB, Olsson CA, Benson MC, McKiernan JM. Mitchell RE, et al. Among authors: olsson ca. Urology. 2006 Feb;67(2):368-72. doi: 10.1016/j.urology.2005.08.036. Urology. 2006. PMID: 16461087

9

High-grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomy.

Pierorazio PM, Lambert SM, Matsukhani M, Sprenkle PC, McCann TR, Katz AE, Olsson CA, Benson MC, McKiernan JM. Pierorazio PM, et al. Among authors: olsson ca. BJU Int. 2007 Nov;100(5):1066-70. doi: 10.1111/j.1464-410X.2007.07115.x. Epub 2007 Sep 3. BJU Int. 2007. PMID: 17784880

10

An algorithm for prostate cancer detection in a patient population using prostate-specific antigen and prostate-specific antigen density.

Benson MC, McMahon DJ, Cooner WH, Olsson CA. Benson MC, et al. Among authors: olsson ca. World J Urol. 1993;11(4):206-13. doi: 10.1007/BF00185070. World J Urol. 1993. PMID: 7508785

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

435 results

Search Page

Filters